reported that ATAD2 is involved in the regulation of the expression and activation of BRCA1, Chk1 and Chk2 in response to DNA damaging anti-cancer drugs, suggesting that ATAD2 is a key mediator of the DNA damage response and repair mechanism.143. This evidence concerns the gene CHEK1 and cancer.